Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
37.48
+0.52 (1.41%)
Last updated: Aug 26, 2025

SHE:301281 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
3,8463,2393,686---
Upgrade
Market Cap Growth
44.23%-12.13%----
Upgrade
Enterprise Value
3,5752,7863,045---
Upgrade
Last Close Price
35.5229.7333.44---
Upgrade
PE Ratio
57.1753.7447.85---
Upgrade
PS Ratio
8.466.998.24---
Upgrade
PB Ratio
2.782.382.77---
Upgrade
P/TBV Ratio
3.042.592.87---
Upgrade
P/OCF Ratio
--99.54---
Upgrade
EV/Sales Ratio
7.876.016.80---
Upgrade
EV/EBITDA Ratio
35.3233.2328.35---
Upgrade
EV/EBIT Ratio
66.8568.7352.07---
Upgrade
Debt / Equity Ratio
0.070.03----
Upgrade
Debt / EBITDA Ratio
0.950.54----
Upgrade
Asset Turnover
0.300.310.420.730.830.77
Upgrade
Inventory Turnover
1.842.252.743.433.132.85
Upgrade
Quick Ratio
4.974.646.861.911.001.05
Upgrade
Current Ratio
6.565.777.912.621.841.77
Upgrade
Return on Equity (ROE)
4.93%4.48%8.33%19.20%20.24%22.33%
Upgrade
Return on Assets (ROA)
2.17%1.68%3.45%9.18%10.15%9.89%
Upgrade
Return on Capital (ROIC)
2.38%1.85%3.95%11.69%13.37%13.47%
Upgrade
Return on Capital Employed (ROCE)
3.60%2.80%4.30%16.30%18.40%21.10%
Upgrade
Earnings Yield
1.74%1.86%2.09%---
Upgrade
FCF Yield
-7.20%-11.02%-0.90%---
Upgrade
Dividend Yield
0.56%0.67%0.90%---
Upgrade
Payout Ratio
32.51%54.03%40.16%--2.87%
Upgrade
Buyback Yield / Dilution
0.45%-6.18%-24.38%-0.53%0.47%-0.34%
Upgrade
Total Shareholder Return
1.01%-5.50%-23.48%-0.53%0.47%-0.34%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.